Spironolactone
Spironolactone is an aldosterone antagonist indicated for: The treatment of NYHA Class III-IV heart failure and reduced ejection fraction to increase survival, manage edema, and to reduce the need for hospitalization for heart failure ( 1.1 ).
United States
$4
per month
India
$0
per month
You save
−89%save $4/mo · 89% cheaper
9.1M US scripts/yr$32.4M potential annual savings$36.2M US spend/yr
Drag to rotate · 3D structureC24H32O4S
SMILES: CC(=O)S[C@@H]1CC2=CC(=O)CC[C@@]2([C@@H]3[C@@H]1[C@@H]4CC[C@]5([C@]4(CC3)C)CCC(=O)O5)C
Compare the price
US price$4per month
India price$2per month
You save$258% less
Based on 30 units per month. US $0.13 vs India $0.06 per unit.
Total over 1 periodSave $2$4 → $2
The bigger picture
Spironolactone is filled about 9.1M times a year under Medicare Part D. At the prices above, that works out to roughly:
Est. annual US spend
$36.2M
If sourced from India
$3.8M
Potential annual savings
$32.4M
−89%
Rough estimate. Based on Medicare Part D prescription volume (not the entire US market) scaled by the representative monthly price — actual totals depend on dose, duration and coverage.